Takeaways
#- Greenberg treated the risk to Hims' weight-loss business as relevant even while the stock remained above his original warning price.
- Strazza saw decisive damage to the shorter-term setup, while distinguishing it from a fully established primary downtrend.
- His longer-term bearish confirmation required further deterioration, including a lower low and a lower high.
- The failed call position showed how a trader could accept the possibility of losing the entire premium while a business-focused analyst preferred avoiding the risk.
Steve Strazza had bought Hims & Hers calls the previous week. The position had nearly doubled, he had taken no profits, and the sudden selloff had left him describing calls headed toward zero. Sitting opposite him in Stock Market TV's June 24, 2025 Special Report was Herb Greenberg, who had been warning about the company since May 2024.
Spencer Israel brought the two together after Novo Nordisk announced that it was ending its collaboration with Hims & Hers. Greenberg approached the situation through business risk. Strazza wanted to establish how much of that risk the price was now confirming.
Greenberg's warning had survived a rising stock
Greenberg acknowledged that Hims was still substantially above the price at which he had first flagged it, even after the sharp drop. His work had identified a vulnerability rather than timed the end of the advance. A rising stock did not, in his view, resolve that underlying concern.
The central question was what would happen if the company's ability to sell compounded GLP-1 treatments were restricted or materially reduced. Novo's decision to end the collaboration brought the dispute over compounding into immediate focus. Greenberg regarded potential regulatory action as a serious business risk.
He also wanted investors to examine the rest of the company rather than extrapolate the weight-loss business's growth indefinitely. What would remain if that source of growth became much less important? He was not offering a precise revenue breakdown, but he considered the dependency itself essential to the analysis.
Greenberg explained that he did not short stocks. His role was to identify and publish risks, which meant his exposure was reputational. Avoiding a loss could be a valid response to a warning; investors did not have to turn every concern into a short position.
Strazza separated tactical damage from a new long-term trend
Strazza did not dismiss the business concerns. He said he read Greenberg's research, but would follow the market when it disagreed with either of them. Hims had repeatedly recovered from adverse headlines and remained a major winner during the cycle.
This decline looked different to him. A bullish continuation pattern had failed decisively, damaging the shorter-term trend. That was an early step that could lead to a larger reversal.
It was not yet proof that the entire primary uptrend had ended. Strazza pointed out that the stock remained above its 200-day moving average. An anchored VWAP from the October 2023 low and a longer-term trend line were lower still. In his reading, Hims could fall into the low $30s to test that trend line while retaining its broader pattern of higher highs and higher lows.
For a stronger long-term bearish case, he wanted to see a lower low followed by a lower high. By the end of the discussion, he was not bullish tactically and considered another five to 10 points of downside plausible. The larger short thesis still required additional confirmation.
The options loss was part of the disagreement
Greenberg asked whether Strazza would change anything about the failed trade. Strazza said he would still take that type of setup in the same environment. He had been buying a basket of speculative growth stocks, understood that individual positions could fail and sized the calls on the assumption that the entire premium could be lost.
That did not make the Hims loss smaller. It explained why he judged the decision within a group of trades rather than requiring every company to work. Greenberg remained focused on the business conditions that could produce the abrupt move against an otherwise appealing chart.
Both saw value in combining the approaches. Strazza preferred situations in which fundamentals and technicals agreed. Greenberg wanted traders to recognize that an apparently sudden headline could be the arrival of a risk that had been present for months. In Hims, the next test was whether the initial chart break developed into the lower lows and lower highs Strazza was watching.
Questions and answers
#Questions about the original 2025-06-24 episode.
What was Greenberg's main business concern?
He asked how Hims would perform if access to compounded GLP-1 treatments were restricted or substantially reduced. He considered the dispute with Novo Nordisk and possible regulatory action risks that a strong stock chart did not remove.
What additional chart evidence did Strazza want before a longer-term short?
The failed bullish pattern had damaged the tactical trend, but the stock remained above longer-term reference points. He wanted to see a lower low and then a lower high before treating the move as a more established primary downtrend.
Why did Strazza still defend taking the failed call trade?
He said it fit the speculative-growth setups he was buying across a basket of positions. He sized the calls knowing the full premium could be lost. Greenberg's question was whether the underlying business risk should have changed that decision.
Adapted by Stock Market TV Editorial from the original video. Source date: . Article published: .